SAB BIOTHERAPEUTICS INC

SABSNASDAQ

🏆 #3290 by market capEarnings Nov 11US Equity

——

Quote unavailable

24h—

7d—

14d—

30d—

ytd—

1y—

🏦Market Cap

$291M

Small Cap

📈Revenue Growth (YoY)

-100.0%

Declining

📊Gross Margin

0.0%

Thin

💵FCF Margin

0.0%

Thin

⚖️P/S Ratio

0.0x

Cheap

Otter Score

—

Insufficient data

🔭

No analyst ratings for SABS

We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.